Improving drug development for diverse populations
1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
This study is working to make sure that new medicines are safe and effective for everyone, especially African Americans and Latinos, by training a diverse group of researchers and improving how drugs are developed.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beckman Research Institute/city of Hope NIH-funded |
| Lab location | 1 site (Duarte, United States) |
| Project ID | NIH-10933458 on NIH RePORTER |
What this research studies
This research focuses on addressing disparities in drug development by ensuring that drugs are tested and optimized for diverse populations, particularly African Americans and Latinos. The project aims to build resources, infrastructure, and training programs to mentor a new generation of researchers who reflect the diversity of the communities they serve. By enhancing collaboration between institutions, the research seeks to reduce the inequities present in the drug discovery pipeline, ensuring that new medications are safe and effective for all populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American and Latino individuals who may be affected by conditions like breast cancer.
Not a fit: Patients who are not part of the African American or Latino communities may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective medications for diverse populations, reducing health disparities.
How similar studies have performed: Other research has shown success in addressing health disparities through community engagement and diverse clinical trial participation, making this approach promising.
Where this research is happening
Duarte, United States
- Beckman Research Institute/city of Hope — Duarte, United States (Active)
Researchers
- Principal investigator: Seewaldt, Victoria L. — Beckman Research Institute/city of Hope
- Study coordinator: Seewaldt, Victoria L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.